Equillium Inc (EQ) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.74
• Market Cap: $111.44M
• EPS: $-0.58
• 52-Week High: $2.35
• 52-Week Low: $0.27

Market Sentiment

Equillium Inc currently has a Bullish sentiment score of 0.26.

About Equillium Inc

Equillium, Inc. is a clinical-stage biotechnology company headquartered in La Jolla, California, dedicated to developing novel therapeutics for severe autoimmune and inflammatory disorders that currently have no effective treatment options. Utilizing its proprietary platform, the company focuses on innovative therapies that target specific immuno-inflammatory pathways, thereby positioning itself as a leader in addressing complex diseases. With a promising pipeline of clinical candidates, Equi...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Equillium Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does EQ pay dividends?

Equillium Inc (EQ) does not currently pay a regular dividend.

What is EQ's market cap?

Equillium Inc (EQ) has a market capitalization of $111.44M with a current stock price of $1.74.